Search

Search Constraints

You searched for: Subject 616.994061

Search Results

5. 100P Immunotherapy around the clock: Impact on stage IV melanoma. (December 2022)

8. 103P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of Chinese extensive-stage small cell lung cancer (ORIENTAL): Preliminary safety and efficacy results. (December 2022)

9. 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. (December 2022)